Effects of intravenous caffeine administered to healthy males during sleep

Depression and Anxiety

Volumn 5, Issue 1, 1997, Pages 21-28

  Lin, Albert Shi Kwang ^a   Uhde, Thomas W ^b,d   Slate, Shiyoko O ^c   McCann, Una D ^c  

^a TAIPEI CITY PSYCHIATRIC CENTER   (Taiwan)

^b WAYNE STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; Arousal; Panic attacks; Pharmacological challenge; Sleep panic

Indexed keywords

CAFFEINE;

AROUSAL; ARTICLE; COFFEE; CORTICOTROPIN BLOOD LEVEL; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONREM SLEEP; PANIC; PRIORITY JOURNAL; SLEEP; SLEEP DISORDER;

ADRENOCORTICOTROPIC HORMONE; ADULT; AROUSAL; CAFFEINE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFUSIONS, INTRAVENOUS; LACTIC ACID; MALE; PITUITARY-ADRENAL SYSTEM; POLYSOMNOGRAPHY; SLEEP, REM; WAKEFULNESS;

EID: 0031405267     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1997)5:1<21::AID-DA4>3.0.CO;2-8     Document Type: Article

References (36)

1. Abelson JL, Nesse RM (1994) Pentagastrin in fusions in patients with panic disorder I. Symptoms and cardiovascular responses. Biol Psychiatry 36:73-83.
2. Adler CM, Craske MC, Barlow DH (1987) Relaxation-induced panic (RIP): When resting isn't peaceful. Intergrative Psychiatry 5:94-112.
3. American Psychiatric Association Committee on Nomenclature and Statistics (1987) Diagnostic and Statistical Manual of Mental Disorders, ed 3, revised. American Psychiatric Association, Washington, DC.
4. Beck AT, Ward CH, Mendelson M, et al. (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:53-63.
5. Born J, Kern W, Bieber K, Fehm-Wolfsdorf G, Schiebe M, Fehm HL (1986) Night-time plasma cortisol secretion is associated with specific sleep stages. Biol Psychiatry 21:1415-1424.
6. Charney DS, Heninger GR, Breier A (1984) Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 41:751-763.
7. Charney DS, Heninger GR, Jatlow PI (1985) Increased anxiogenic effects of caffeine in panic disorder. Arch Gen Psychiatry 42:233-243.
8. Follenius M, Branderberger G, Simon C, Schlienger JL (1988) REM sleep in humans begins during decreased secretory activity of the anterior pituitary. Sleep 11:546-555.
9. Germine M, Goddard AW, Woods SW, Charney DS, Heninger GR (1992) Anger and anxiety responses to m-chlorophenyl-piperazine in generalized anxiety disorder. Biol Psychiatry 32:457-461.
10. Goldstein A, Kaizer S, Whitby O (1969) Psychotropic effects of caffeine in man. IV. Quantitative and qualitative differences associated with habituation to coffee. Clin Pharmacol Ther 10:489-497.
11. Griez E, de Loof C, Pols H, Zandbergen J, Lousberg H (1990) Specific sensitivity of patients with panic attacks to carbon dioxide inhalation. Psychiatry Res 31:193-199.
12. Henauer SA, Gillespie HK, Hollister LE (1984) Yohimbine and the model anxiety state. J Clin Psychiatry 45:512-515.
13. Jasper HH (Committee Chairman) (1958). The ten twenty electrode system of the International Federation. Electroenceph: Clin Neurophysiol 10:371-375.
14. Karacan I, Thronby JI, Anch M, Booth GH, Williams RL, Salis PJ (1976) Dose-related sleep disturbances induced by coffee and caffeine. Clin Pharmacol Ther 20:682-689.
15. Klein E, Zohar J, Geraci MF, Murphy DL, Uhde TW (1992) Anxiogenic effects of m-CPP in patients with panic disorder: Comparison to caffeine's anxiogenic effects. Biol Psychiatry 30:973-984.
16. Koenigsberg HW, Pollak C, Sullivan T (1987) The sleep lactate infusion: Arousal and the panic mechanism. Biol Psychiatry 22:789-791.
17. Koenigsberg HW, Pollack CP, Fine J, Kakuma T (1992) Lactate sensitivity in sleeping panic disorder patients and healthy controls. Biol Psychiatry 32:530-542.
18. Koenigsberg HW, Pollack CP, Fine J, Kakuma T (1994) Cardiac and respiratory activity in panic disorder: Effects of sleep and sleep lactate infusions. 151(8):1148-1152.
19. McCann UD, Slate SO, Geraci M, Uhde TW (1995) Peptides and anxiety: A dose-response evaluation of pentagastrin in healthy volunteers. Anxiety 1:258-267.
20. Mellman TA, Udhe TW (1989) Electroencephalographic sheep in panic disorder: A focus on sleep-related panic attacks. Arch Gen Psychiatry 46:178-184.
21. Penetar D, McCann U, Thorne D, Kamimori G, Galinski C, Sing H, Thomas M, Belenky G (1992) Caffeine reversal of sleep deprivation effects on alertness and mood. Psychopharmacology 112:359-365.
22. Pitts FN, Jr., McClure JN, Jr. (1967) Lactate metabolism in anxiety neurosis. N Engl J Med 277:1329-1336.
23. Pyke RE, Greenberg HS (1986) Norepinephrine challenges in panic patients. J Clin Psychopharmacol 6:279-285.
24. Ravard S, Dourish CT (1990) Cholecystokinin and anxiety. Trends Pharmacol Sci 11:271-273.
25. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Public Health Services, U.S. Government Printing Office, Washington, D.C.
26. Schleyer B, Aaronson C, Mannuzza S, Martin LY, Fyer AJ (1990) Schedule for Affective Disorders and Schizophrenia, Lifetime Version, Modified for the Study of Anxiety Disorders, Revised. New York State Psychiatric Institute, New York.
27. Shear MK (1990) Psychological Perspectives on Pharmacologic Challenge Testing. In: Ballenger JC (ed), Neurobiology of Panic Disorder, Wiley-Liss, New York, pp 173-186.
28. Spielberger CD, Gorsuch RW, LuShene RE (1970) State-Trait Anxiety Inventory. Palo Alto, California. Consulting Psychologists Press, Inc.
29. Spindel ER, Wurtman RJ, McCall A, Carr DB, Conlay L, Griffith L, Arnold MA (1984) Neuroendocrine effects of caffeine in normal subjects. Clin Pharmacol Ther 36:402-407.
30. Taylor CB, Sheikh J, Agras WS, Roth WT, Margraf J, Ehlers A, Maddock RJ, Gossard D (1986) Ambulatory heart rate changes in patients with panic attacks. Am J Psychiatry 143:478-482.
31. Uhde TW, Boulenger J-P, Jimerson DC, Post RM (1984) Caffeine: Relation to human anxiety, plasma MHPG, and cortisol. Psychopharmacol Bull 20:426-430.
32. Uhde TW, Bierer LM, Post RM (1985) Caffeine-induced escape from dexamethasone suppression. Arch Gen Psychiatry 42:737-738.
33. Udhe TW, Tancer ME (1989) Chemical models of panic: A review and critique. In: Tyrer P (ed), Psychopharmacology of Anxiety, Oxford Medical Publications, New York, pp. 109-131.
34. Uhde TW. The Anxiety Disorders: Phenomenology and Treatment of Core Symptoms and Associated Sleep Disturbances. In: Principles and Practice of Sleep Medicine, M.H. Kryger, T. Roth and W.C. Dement (Eds.) W.B. Saunders Co., Philadelphia, 1994.
35. Uhde TW (1995) Caffeine-induced anxiety: An ideal chemical model of panic disorder? In: Einstein Monograph Series in Psychiatry, Gregory Asnis and Herman Van Praag (Eds.); Wiley-Liss, New York, pp. 181-205.
36. Woods SW, Charney DS, Goodman WK, Heninger GR (1988) Carbon dioxide-induced anxiety: Behavioral, physiologic, and biochemical effects of carbon. Arch Gen Psychiatry 45:43-52.